MR
MRM.US Medirom Healthcare Technologies Inc
- Market cap
- USD 2.19M
- P/E
- 0.7x
- P/B
- 1.46x
- ROE
- 19.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2026.
Is MRM.US undervalued?
Graham numberThe Graham number of Medirom Healthcare Technologies Inc cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Medirom Healthcare Technologies Inc fundamental analysis
No fundamental analysis for Medirom Healthcare Technologies Inc yet.
Medirom Healthcare Technologies Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Medirom Healthcare Technologies Inc
MEDIROM Healthcare Technologies Inc., together with its subsidiaries, provides holistic health services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The Relaxation Salon segment develops, owns, operates, franchises, and supports relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual …
Full company profileMedirom Healthcare Technologies Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Mar 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Medirom Healthcare Technologies Inc annual financial statements (JPY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 3.43B | 3.91B | 3.34B | 5.41B | 6.95B | 6.83B | 8.30B | 4.04M | 2.45B |
| Gross Profit | 957M | 951M | 429M | 1.42B | 1.90B | 1.57B | 2.25B | 3.90M | 2.44B |
| Operating Income | 73.3M | 34.4M | -746M | -380M | 97.0M | -392M | -18.1M | 414K | 283M |
| EBITDA | 158M | 125M | -551M | -228M | 374M | 310M | 387M | 514K | 333M |
| Net Income | 66.3M | 17.3M | -539M | -991M | 149M | 115M | 149M | 375K | 254M |
| EPS | 14 | 4.06 | -134 | -203 | 27 | 22 | 25 | 0.05 | 32 |
| Balance Sheet | |||||||||
| Total Assets | 4.52B | 4.76B | 5.71B | 5.75B | 6.75B | 6.85B | 8.09B | 4.16B | 4.16B |
| Total Liabilities | 4.64B | 4.16B | 5.22B | 5.96B | 6.81B | 6.63B | 6.90B | 2.82B | 2.82B |
| Shareholders' Equity | -118M | 600M | 491M | -208M | -59.4M | 211M | 933M | 1.33B | 1.33B |
| Cash & Short-term Investments | 245M | 552M | 1.47B | 397M | 606M | 133M | 336M | 20.1M | 20.1M |
| Total Debt | 2.85B | 2.36B | 2.56B | 2.79B | 3.23B | 3.65B | 3.96B | 2.33B | 2.33B |
| Cash Flow | |||||||||
| Operating Cash Flow | 142M | 7.87M | -366M | -557M | -686M | -632M | -1.33B | - | -1.78B |
| Capital Expenditure | 34.3M | 7.41M | 73.6M | 114M | 121M | 136M | 565M | - | 1.12B |
| Free Cash Flow | 108M | 464K | -440M | -671M | -806M | -768M | -1.90B | - | -2.90B |
| Ratios | |||||||||
| ROE | - | 2.9% | -109.8% | - | - | 54.6% | 15.9% | 0.0% | 19.0% |
| ROA | 1.5% | 0.4% | -9.4% | -17.2% | 2.2% | 1.7% | 1.8% | 0.0% | 6.1% |
| Net Profit Margin | 1.9% | 0.4% | -16.1% | -18.3% | 2.1% | 1.7% | 1.8% | 9.3% | 10.4% |
| Debt to Equity | - | 3.94x | 5.21x | - | - | 17.31x | 4.24x | 1.75x | 1.75x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Medirom Healthcare Technologies Inc dividends
Medirom Healthcare Technologies Inc has not paid dividends in the last 7 fiscal years.
Who owns Medirom Healthcare Technologies Inc
- Insiders 24.04%
- Institutions 1.72%
- Public & others 74.25%
- Shares outstanding 7.90M
- Free float 5.76M
Top funds holding MRM.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Core Guided Moderate Tax-Managed | 16.00 | 0.00% | 0.00% | Sep 2023 |
Top institutions holding MRM.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Citadel Advisors Llc | 56.1K | 0.71% | 0.00% | Jun 2026 |
| HRT FINANCIAL LLC | 54.8K | 0.69% | +359.93% | Jun 2026 |
| UBS Group AG | 27.2K | 0.34% | +2.38% | Jun 2026 |
| Virtu Financial LLC | 15.8K | 0.20% | 0.00% | Jun 2026 |
| TWO SIGMA SECURITIES, LLC | 10.6K | 0.13% | -24.41% | Jun 2026 |
| GAMMA Investing LLC | 3.80K | 0.05% | -40.74% | Jun 2026 |
| Rhumbline Advisers | 3.10K | 0.04% | 0.00% | Sep 2026 |
| SRS Capital Advisors Inc | 300.00 | 0.00% | 0.00% | Jun 2026 |
Medirom Healthcare Technologies Inc company profile
- Company name
- Medirom Healthcare Technologies Inc
- Ticker
- MRM.US
- Exchange
- USA Stocks
- Listed since
- Dec 29, 2020
- Sector
- Consumer Cyclical
- Industry
- Health Care Providers & Services
- Employees
- 334
- Fiscal year end
- December
- Address
- 2-3-1 Daiba, Tokyo, Japan, 135 0091
- Phone
- 81 3 6721 7364
- Website
- medirom.co.jp
About Medirom Healthcare Technologies Inc
MEDIROM Healthcare Technologies Inc., together with its subsidiaries, provides holistic health services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The Relaxation Salon segment develops, owns, operates, franchises, and supports relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. This segment operates relaxation salons under the Re.Ra.Ku and Ruam Ruam brands. The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program that utilizes Lav, an on-demand health monitoring smartphone application, as well as MOTHER Bracelet for fitness and health applications; and provides preventative healthcare services utilizing nutritionists and health nurses. The Luxury Beauty segment manages and operates hair salons under the ZACC brand name. The company also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques. The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
Medirom Healthcare Technologies Inc management
3- Mr. Kouji EguchiCEO & Representative Director · born 1974
- Mr. Fumitoshi FujiwaraCFO & Director · born 1967
- Mr. Akira AokiExecutive Officer & Chief Medical Officer